Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V58435 | Lenalidomide-C10-OH | 2503018-12-8 | Lenalidomide-C10-OH (6a) is an intermediate in the preparation /synthesis of INY-03-041. |
![]() |
V61651 | Levetiracetam-d6 (ring-d6) (UCB L059-d6 (ring-d6)) | 1133229-30-7 | Levetiracetam-d6 (ring-d6) can be used as an internal standard for the determination of Levetiracetam content in whole blood. |
![]() |
V70387 | Lexanersen (WVE-120102) | 2073015-40-2 | Lexanersen (WVE-120102) is an oligonucleotide useful in Huntington's disease study. |
![]() |
V70382 | Lexanersen sodium (WVE-120102 sodium) | 2223673-42-3 | Lexanersen sodium is an oligonucleotide useful in Huntington's disease study. |
![]() |
V58844 | LI-2242 | 2762762-17-2 | LI-2242 is an inhibitor (blocker/antagonist) of phytate kinase (IP6K). |
![]() |
V62249 | LIN28 inhibitor LI71 enantiomer | 956189-58-5 | LIN28 inhibitor LI71 enantiomer is the less active enantiomer of LIN28 inhibitor LI71. |
![]() |
V62484 | Linaprazan glurate (X842) | 1228559-81-6 | Linaprazan glurate inhibits exogenously or endogenously stimulated gastric acid secretion. |
![]() |
V56871 | Linoleamide (Linoleic acid amide) | 3999-01-7 | Linoleamide is a linoleic acid amide. |
![]() |
V60236 | Lipase Substrate | 195833-46-6 | Lipase Substrate may be utilized to detect lipase activity. |
![]() |
V59568 | Lithium citrate (lithium citrate; Litarex) | 919-16-4 | Lithium citrate reduces excess N-acetyl aspartate in the brain in Canavan disease. |
![]() |
V57945 | LM2I | 2055494-50-1 | LM2I is an analogue of spinosad (SPA). |
![]() |
V61664 | LMP7-IN-2 | 1613317-24-0 | LMP7-IN-2 is an LMP7 inhibitor useful in the treatment of related inflammatory diseases and disorders. |
![]() |
V58546 | LNnDFH I (Lacto-N-neo-difucohexaose I) | 62469-99-2 | LNnDFH I is a naturally occurring compound that can be extracted from human urine. |
![]() |
V62287 | LNP Lipid-8 | 2408140-60-1 | LNP Lipid-8 (11-AM) is an ionizable lipid that works as a lipid nanoparticle (LNP) to deliver siRNA to T cells without targeting ligands. |
![]() |
V64350 | Locostatin (UIC-1005) | 90719-30-5 | Locostatin (UIC-1005) is a potent RKIP inhibitor. |
![]() |
V61500 | Lomardexamfetamine (KP 106) | 1032291-80-7 | Lomardexamfetamine (KP 106) is an orally bioactive central nervous system/CNS activator consisting of d-amphetamine and a ligand. |
![]() |
V59687 | Lometraline hydrochloride | 30060-91-4 | Lometraline HCl is an aminotetralin analogue used in Parkinson's disease (PD) research. |
![]() |
V57576 | Lonazolac | 53808-88-1 | Lonazolac is a nonsteroidal antirheumatic agent. |
![]() |
V64356 | LONP1-IN-2 | 2729981-17-1 | LONP1-IN-2 (compound 9d) is a potent and specific LONP1 inhibitor (antagonist) with IC50s of 0.187 μM and >10 μM for LONP1 and 20S proteasome, respectively. |
![]() |
V62265 | LP-184 | 924835-67-6 | LP-184 (compound 6), an acyl fluoroethylene analog, inhibits tumor growth. |